• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Scynexis Inc (NQ: SCYX )

    2.096 +0.011 (+0.52%)
    Streaming Delayed Price Updated: 10:46 AM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,162
    Open 2.110
    Bid (Size) 2.090 (1)
    Ask (Size) 2.120 (4)
    Prev. Close 2.085
    Today's Range 2.096 - 2.140
    52wk Range 1.350 - 3.870
    Shares Outstanding 37,175,665
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning! 
    Via InvestorPlace
    3 Stocks Under $10 With the Potential for Massive Gains
    Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries. 
    Via InvestorPlace

    Performance

    YTD
    -5.17%
    -5.17%
    1 Month
    +10.89%
    +10.89%
    3 Month
    +42.57%
    +42.57%
    6 Month
    +15.79%
    +15.79%
    1 Year
    -25.94%
    -25.94%

    More News

    Read More
    3 Dirt-Cheap Drug Developers With Blockbuster Potential
    Via InvestorPlace
    7 Undervalued Biotech Stocks to Buy for Big-Time Returns
    Via InvestorPlace
    Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing?
    Via Chartmill
    Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025
    Via InvestorPlace
    3 Stocks Under $10 With Mammoth Growth Prospects
    Via InvestorPlace
    SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    5 Value Stocks To Watch In The Healthcare Sector
    Via Benzinga
    SCYX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors with Losses to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    SCYX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SCYNEXIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    SCYNEXIS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    SCYX DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    SCYX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SCYX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    SCYNEXIS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    ROSEN, LEADING INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.